Correlation Between Eli Lilly and Fideicomiso Irrevocable

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Fideicomiso Irrevocable at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Fideicomiso Irrevocable into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Fideicomiso Irrevocable F2061, you can compare the effects of market volatilities on Eli Lilly and Fideicomiso Irrevocable and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Fideicomiso Irrevocable. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Fideicomiso Irrevocable.

Diversification Opportunities for Eli Lilly and Fideicomiso Irrevocable

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Eli and Fideicomiso is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Fideicomiso Irrevocable F2061 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fideicomiso Irrevocable and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Fideicomiso Irrevocable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fideicomiso Irrevocable has no effect on the direction of Eli Lilly i.e., Eli Lilly and Fideicomiso Irrevocable go up and down completely randomly.

Pair Corralation between Eli Lilly and Fideicomiso Irrevocable

If you would invest (100.00) in Eli Lilly and on August 30, 2024 and sell it today you would earn a total of  100.00  from holding Eli Lilly and or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Eli Lilly and  vs.  Fideicomiso Irrevocable F2061

 Performance 
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Eli Lilly is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Fideicomiso Irrevocable 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Fideicomiso Irrevocable F2061 are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Fideicomiso Irrevocable is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Eli Lilly and Fideicomiso Irrevocable Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eli Lilly and Fideicomiso Irrevocable

The main advantage of trading using opposite Eli Lilly and Fideicomiso Irrevocable positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Fideicomiso Irrevocable can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fideicomiso Irrevocable will offset losses from the drop in Fideicomiso Irrevocable's long position.
Eli Lilly vs. Lloyds Banking Group
Eli Lilly vs. Grupo Carso SAB
Eli Lilly vs. GMxico Transportes SAB
Eli Lilly vs. Capital One Financial
The idea behind Eli Lilly and and Fideicomiso Irrevocable F2061 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Fideicomiso Irrevocable vs. Fibra Terrafina
Fideicomiso Irrevocable vs. Fibra Shop
Fideicomiso Irrevocable vs. Fibra Danhos
Fideicomiso Irrevocable vs. FIBRA Macquarie Mxico
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY